(Q71848491)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8950526%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

title

Timed killing kinetic studies of the interaction between ciprofloxacin and beta-lactams against gram-negative bacilli (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8950526%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

2

C C Knapp

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8950526%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

4

J A Washington

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8950526%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

author name string

J K Pohlman

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8950526%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

M D Ludwig

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8950526%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

publication date

1 September 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8950526%20AND%20SRC:MED&resulttype=core&format=json

Diagnostic Microbiology and Infectious Disease

21 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8950526%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8950526%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8950526%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

29-33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8950526%20AND%20SRC:MED&resulttype=core&format=json

In vitro activity of ciprofloxacin in combination with ceftazidime, aztreonam, and azlocillin against multiresistant isolates of Pseudomonas aeruginosa

21 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2896%2900174-5

7 January 2021

Comparison of methodologies for synergism testing of drug combinations against resistant strains of Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2896%2900174-5

7 January 2021

Synergy of ciprofloxacin and azlocillin in vitro and in a neutropenic mouse model of infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2896%2900174-5

7 January 2021

In-vitro study of the activity of ciprofloxacin alone and in combination against strains of Pseudomonas aeruginosa with multiple antibiotic resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2896%2900174-5

7 January 2021

Bactericidal activities of DU-6859a and clinafloxacin (CI-960) against staphylococci

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2896%2900174-5

7 January 2021

In vitro synergy studies with ciprofloxacin and selected beta-lactam agents and aminoglycosides against multidrug-resistant Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2896%2900174-5

7 January 2021

Effect of antibiotic carry-over on bacterial counting by ‘spiral plating’

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2896%2900174-5

7 January 2021

10.1016/S0732-8893(96)00174-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8950526%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference